![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessStrategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience
The 2021 European Society of Cardiology (ESC) Guidelines recommend the use of four different classes of drugs for heart failure with reduced ejection fraction (HFrEF): beta blockers (BB), sodium-glucose cotran...
-
Article
Open AccessAdvanced Cardiovascular Magnetic Resonance Imaging in Takotsubo Syndrome: Update on Feature Tracking and Tissue Map**
Takotsubo syndrome (TTS) is an intriguing clinical entity characterized by transient myocardial dysfunction. The precise pathophysiological mechanism of TTS is still unknown, but recent evidence suggests a cen...
-
Article
Cardiovascular Risk Profile in Master Paralympic Athletes, a High-Risk Undertreated Population: A Cross-Sectional Longitudinal Study
Recently, European Society of Cardiology (ESC) validated a prediction model to estimate 10-year fatal and non-fatal cardiovascular disease risk (CVDR) in individuals (aged 40–60 years) without previous cardiov...
-
Article
The role of cardiac magnetic resonance in sports cardiology: results from a large cohort of athletes
Cardiac magnetic resonance (CMR) provides information on morpho-functional abnormalities and myocardial tissue characterisation. Appropriate indications for CMR in athletes are uncertain.
-
Article
Open AccessTelemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients
The purpose of this review is to explore the benefits and controversies that telemedicine (TM), applied to patients with heart failure (HF), can provide in terms of diagnosis, therapeutic management, and progn...
-
Article
Open AccessMedical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
The purpose of this review is to overview the most relevant and recent knowledge regarding medical management in pulmonary arterial hypertension (PAH).
-
Article
Open AccessSodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Sodium-glucose cotransporter 2 inhibitors (SGLT2i), initially born as anti-diabetic drugs, have shown many beneficial effects on the cardiovascular system, in particular against heart failure (HF). HF is a com...
-
Chapter
Cardiac Remodeling Versus Cardiomyopathies in Athletes
Prolonged and intensive training results in morphological and functional remodeling of cardiac chambers. Several determinants affect the remodeling including sport disciplines and the volume and intensity of t...
-
Article
Open AccessPrecision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning
Measurement of cardiac structure and function from images (e.g. volumes, mass and derived parameters such as left ventricular (LV) ejection fraction [LVEF]) guides care for millions. This is best assessed usin...
-
Article
Open AccessT2-map** increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study
Early detection of myocardial involvement can be relevant in coronavirus disease 2019 (COVID-19) patients to timely target symptomatic treatment and decrease the occurrence of the cardiac sequelae of the infec...
-
Article
Open AccessMyocardial contractility recovery following acute pressure unloading after transcatheter aortic valve intervention (TAVI) in patients with severe aortic stenosis and different left ventricular geometry: a multilayer longitudinal strain echocardiographicanalysis
Aim of the present study was to describe the left ventricular longitudinal strain (LS) in all myocardial layers in patients with severe aortic stenosis (AS), preserved left ventricular ejection fraction (LVEF)...
-
Article
Open AccessCardiovascular Magnetic Resonance and Sport Cardiology: a Growing Role in Clinical Dilemmas
Exercise training induces morphological and functional cardiovascular adaptation known as the “athlete’s heart” with changes including dilatation, hypertrophy, and increased stroke volume. These changes may ov...
-
Article
CMR in Hypertrophic Cardiac Conditions—an Update
Myocardial left ventricular (LV) hypertrophy (LVH) is a common phenotype associated to increased morbidity and mortality. Beyond an accurate LV mass quantification, cardiovascular magnetic resonance (CMR) can ...
-
Article
Open AccessCorrection to: Structural and myocardial dysfunction in heart failure beyond ejection fraction
The original version of this article unfortunately contained a mistake.
-
Article
Open AccessStructural and myocardial dysfunction in heart failure beyond ejection fraction
Heart failure is a multifaceted syndrome addressing for a high rate of death among the general population. The common approach to this disease has been always based on the evaluation of the left ventricular ej...
-
Article
Open AccessHematocrit, iron and HDL-cholesterol explain 90% of variation in native blood T1
-
Article
Open AccessCMR findings in high endurance veteran athletes - a 247 subject study
-
Article
Open AccessNative myocardial T1 and ECV with age and gender develo** normal reference ranges - a 94 healthy volunteer study
-
Article
Open AccessExtracellular volume quantification in isolated hypertension - changes at the detectable limits?
Diffuse myocardial fibrosis (DMF) is important in cardiovascular disease, however until recently could only be assessed by invasive biopsy. We hypothesised that DMF measured by T1 map** is elevated in isolat...
-
Article
Open AccessAbnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
Sarcomeric gene mutations cause hypertrophic cardiomyopathy (HCM). In gene mutation carriers without left ventricular (LV) hypertrophy (G + LVH-), subclinical imaging biomarkers are recognized as predictors of...